Case series: Adderall® augmentation of serotonin reuptake inhibitors in childhood-onset obsessive compulsive disorder

Journal of Child and Adolescent Psychopharmacology

Volumn 12, Issue 2, 2002, Pages 165-171

  Owley, Thomas ^a   Owley, Soyna ^a   Leventhal, Bennett ^a   Cook Jr , Edwin H ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; CITALOPRAM; FLUOXETINE; FLUVOXAMINE; METHYLPHENIDATE; PAROXETINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE; AMPHETAMINE DERIVATIVE;

ADULT; AGGRESSION; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR THERAPY; CASE REPORT; CHILD PSYCHIATRY; COGNITIVE THERAPY; DISEASE COURSE; DRUG EFFECT; DRUG INDUCED DISEASE; FEMALE; HUMAN; IRRITABILITY; MALE; OBSESSION; RATING SCALE; RESTLESSNESS; SCHOOL CHILD; SLEEP DISORDER; SYMPTOM; CHILD; DRUG COMBINATION; DRUG POTENTIATION; OBSESSIVE COMPULSIVE DISORDER; ONSET AGE; PSYCHOLOGICAL ASPECT;

ADULT; AGE OF ONSET; AMPHETAMINES; CHILD; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; OBSESSIVE-COMPULSIVE DISORDER; SEROTONIN UPTAKE INHIBITORS;

EID: 0035986347     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/104454602760219207     Document Type: Article

References (39)

1. Adderall for obsessive-compulsive disorder
2. Provocation of obsessive-compulsive behaviour and tremor by olanzapine
3. A case report of risperidone-induced obsessive-compulsive symptoms
4. Development of obsessive and depressive symptoms during risperidone treatment
5. Obsessive-compulsive symptoms in schizophrenia: A comparison of olanzapine and placebo
6. Olanzapine treatment of obsessive-compulsive disorder
7. Treatment of risperidone-induced obsessive-compulsive symptoms with sertraline
8. Differential response of psychotic and obsessive symptoms to risperidone in an adolescent
9. Risperidone augmentation of serotonin reuptake inhibitor treatment of pediatric obsessive compulsive disorder
10. Differential effects of psychostimulants and related agents on dopaminergic and serotonergic transporter function
11. Obsessive-compulsive disorder in children and adolescents: A review
12. Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis
13. D-amphetamine in obsessive-compulsive disorder
14. Risperidone in the treatment of affective illness and obsessive-compulsive disorder
15. An update on obsessive-compulsive disorder
16. Methylphenidate in primary obsessive-compulsive disorder
17. Acute psychostimulant challenge in primary obsessive-compulsive disorder
18. 3H]substrate- and cell-specific effects of uptake inhibitors on human dopamine and serotonin transporter-mediated efflux
19. A case report of refractory obsessive-compulsive disorder improved by risperidone augmentation of domipramine treatment
20. Obsessive-compulsive symptoms following stimulants
21. 5-HT receptors: Location, pharmacological, pathological, and physiological role
22. Dopamine agonist treatment of Tourette disorder in children: Results of an open-label trial of pergolide
23. Olanzapine and obsessive-compulsive symptoms
24. Obsessional symptoms associated with risperidone treatment
25. A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder
26. Update on pharmacologic management of OCD: Agents and augmentation
27. Risperidone addition in fluvoxamine-refractory obsessive-compulsive disorder: Three cases
28. Worsening of obsessive-compulsive symptoms following treatment with olanzapine
29. Olanzapine-induced obsessive-compulsive disorder
30. Risperidone augmentation in refractory obsessive-compulsive disorder: An open-label study
31. Beneficial effect of olanzapine in schizophrenic patients with obsessive-compulsive symptoms
32. Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants
33. Therapeutic effect and safety of adjunctive risperidone in refractory obsessive-compulsive disorder (OCD)
34. The pharmacology of antidepressants at the synapse: Focus on newer compounds
35. Risperidone augmentation of SRI treatment for refractory obsessive-compulsive disorder
36. Children's Yale-Brown Obsessive Compulsive Scale: Reliability and validity
37. Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine
38. Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: Amphetamine specificity for inhibition and efflux
39. The cross national epidemiology of obsessive compulsive disorder